Active, not recruitingPhase 2NCT04289779

Study of CAbozantinib in Combination with AtezolizumaB for Muscle-Invasive BladdEr Cancer

Studying Muscular tumor

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Deepak Kilari
Principal Investigator
Deepak Kilari, MD
Medical College of Wisconsin
Intervention
Cabozantinib(drug)
Enrollment
46 enrolled
Eligibility
18 years · All sexes
Timeline
20202025

Study locations (6)

Collaborators

Exelixis · Genentech, Inc. · Medical College of Wisconsin

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT04289779 on ClinicalTrials.gov

Other trials for Muscular tumor

Additional recruiting or active studies for the same condition.

See all trials for Muscular tumor

← Back to all trials